February 1, 2017: Qorvo reports Q3 EPS of $1.35 versus the $1.25 estimate. Revenue also beat coming in at $826.3 million versus $820 million estimate.
But wait, there’s more!
The CEO said, “In the March quarter, we’re forecasting a greater than historical sequential decline as two of our leading customers in China and a (Read More….)
A weekly Saturday night financial show that attempts to predict market direction for the week ahead by looking at a variety of technical and fundamental indicators. This week’s show includes commentary on the Fed’s first and only rate hike in 2016, Eli Lilly’s long-acting Basal Insulin that’s now available in the US, takeover rumors circulating (Read More….)